Celanese Corporation Website

Celanese Corporation

NYSE-CE

Basic

  • Market Cap

    $15.17B

  • EV

    $27.98B

  • Shares Out

    109.22M

  • Revenue

    $10.7B

  • Employees

    12,410

Margins

  • Gross

    23.61%

  • EBITDA

    17.02%

  • Operating

    10.29%

  • Pre-Tax

    11.39%

  • Net

    18.6%

  • FCF

    14.54%

Returns (5Yr Avg)

  • ROA

    12.46%

  • ROTA

    49.62%

  • ROE

    38.01%

  • ROCE

    12.37%

  • ROIC

    12.47%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $161.5

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $1,483M

  • Net Debt

    $12.36B

  • Debt/Equity

    1.84

  • EBIT/Interest

    1.56

Growth (CAGR)

  • Rev 3Yr

    21.31%

  • Rev 5Yr

    8.88%

  • Rev 10Yr

    4.93%

  • Dil EPS 3Yr

    0.62%

  • Dil EPS 5Yr

    15.47%

  • Dil EPS 10Yr

    9.57%

  • Rev Fwd 2Yr

    2.48%

  • EBITDA Fwd 2Yr

    9.74%

  • EPS Fwd 2Yr

    23.75%

  • EPS LT Growth Est

    22.38%

Dividends

  • Yield

  • Payout

    15.28%

  • DPS

    $2.8

  • DPS Growth 3Yr

    3.3%

  • DPS Growth 5Yr

    5.33%

  • DPS Growth 10Yr

    16.09%

  • DPS Growth Fwd 2Yr

    1.84%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Total Revenues

6,297

5,655

8,537

9,673

10,940

10,698

Total Revenues % Chg.

-12%

-10.2%

51%

13.3%

13.1%

7.1%

Cost of Goods Sold, Total

4,691

4,362

5,855

7,293

8,337

8,172

Gross Profit

1,606

1,293

2,682

2,380

2,603

2,526

Selling General & Admin Expenses, Total

502

464

527

690

1,144

1,123

R&D Expenses

67

74

86

112

146

138

Amortization of Goodwill and Intangible Assets

24

22

25

62

164

164

Other Operating Expenses

-1

Other Operating Expenses, Total

593

559

638

864

1,454

1,425

Operating Income

1,013

734

2,044

1,516

1,149

1,101

Interest Expense, Total

-115

-109

-91

-405

-720

-707

Interest And Investment Income

119

132

155

202

165

170

Net Interest Expenses

4

23

64

-203

-555

-537

Income (Loss) On Equity Invest.

182

134

146

220

102

142

Currency Exchange Gains (Loss)

7

-8

-13

-2

-19

-14

Other Non Operating Income (Expenses)

-8

8

10

10

76

94

EBT, Excl. Unusual Items

1,198

891

2,251

1,541

753

786

Restructuring Charges

-110

-13

5

6

-53

-44

Merger & Related Restructuring Charges

-117

Gain (Loss) On Sale Of Investments

1,408

Gain (Loss) On Sale Of Assets

-2

-7

3

5

505

499

Asset Writedown

-31

-2

-14

-15

-15

Legal Settlements

-89

-2

Other Unusual Items

-9

5

-9

-7

-7

EBT, Incl. Unusual Items

988

2,251

2,248

1,421

1,183

1,219

Income Tax Expense

124

247

330

-489

-790

-782

Earnings From Continuing Operations

864

2,004

1,918

1,910

1,973

2,001

Earnings Of Discontinued Operations

-6

-12

-22

-8

-9

-6

Minority Interest

-6

-7

-6

-8

-4

-5

Net Income

852

1,985

1,890

1,894

1,960

1,990

Net Income to Common Incl Extra Items

852

1,985

1,890

1,894

1,960

1,990

Net Income to Common Excl. Extra Items

858

1,997

1,912

1,902

1,969

1,996

Total Shares Outstanding

119.6

114.2

108

108.5

108.9

109.2

Weighted Avg. Shares Outstanding

123.9

117.8

111.2

108.4

108.8

109

Weighted Avg. Shares Outstanding Dil

124.7

118.5

112.1

109.2

109.4

109.5

EPS

6.9

16.8

17

17.5

18

18.3

EPS Diluted

6.8

16.7

16.9

17.3

17.9

18.2

EBITDA

1,369

1,090

2,422

1,985

1,831

1,821

Effective Tax Rate

12.6%

11%

14.7%

-34.4%

-66.8%

-64.2%